Cancer Outcomes in DCIS Patients Without Locoregional Treatment
Abstract
The vast majority of women diagnosed with ductal carcinoma in situ (DCIS) undergo treatment. Therefore, the risks of invasive progression and competing death in the absence of locoregional therapy are uncertain.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 13, 2019
- Source ID
- 10.1093/jnci/djy220
Entities
People
- Donald L. Weaver
- E. Shelley Hwang
- Fengmin Zhao
- Lars J Grimm
- Marc D. Ryser
- Mathias Worni
- Roman Gulati
- Ruth Etzioni
- Sandra J Lee
- Terry Hyslop
Organizations
- National Institutes of Health
- National Science Foundation
- Patient-Centered Outcomes Research Institute
- United States Department of Defense